CME: Cancer

Developed and published by the Angiogenesis Foundation, the CME Cancer App is a peer-reviewed professional, CME program designed to give physicians and nurses state-of-the-art information and expert perspectives on late-breaking clinical data and new concepts on antiangiogenic cancer treatment and clinical trials. Its unique format incorporates clear and concisely written text and graphics. Striking digital 3-D illustrations highlight the steps of tumor angiogenesis at the organ, cell, and molecular level. Each issue features a roster of internationally renowned guest editors who are authorities on treating specific tumor types, such as colorectal, lung, kidney, liver, breast, brain and other cancers. Targeting Tumor Angiogenesis is a convenient way for busy clinicians to keep up with the antiangiogenic field and learn practical information in a timely fashion. It is adapted for digital and print delivery for effective, rapid learning in clinics, classrooms, office, and during travel, and is distributed nationally to over 11,000 oncology professionals.